These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS. Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431 [TBL] [Abstract][Full Text] [Related]
10. Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome. González F; Sia CL; Stanczyk FZ; Blair HE; Krupa ME Endocrine; 2012 Dec; 42(3):726-35. PubMed ID: 22752961 [TBL] [Abstract][Full Text] [Related]
11. Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome. González F; Considine RV; Abdelhadi OA; Acton AJ J Clin Endocrinol Metab; 2020 Jun; 105(6):e2152-67. PubMed ID: 32140727 [TBL] [Abstract][Full Text] [Related]
12. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. Nehir Aytan A; Bastu E; Demiral I; Bulut H; Dogan M; Buyru F Gynecol Endocrinol; 2016 Sep; 32(9):709-713. PubMed ID: 26951881 [TBL] [Abstract][Full Text] [Related]
13. Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome. González F; Kirwan JP; Rote NS; Minium J Am J Obstet Gynecol; 2014 Dec; 211(6):635.e1-7. PubMed ID: 24956549 [TBL] [Abstract][Full Text] [Related]
14. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes. Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477 [TBL] [Abstract][Full Text] [Related]
15. Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome. González F; Considine RV; Abdelhadi OA; Acton AJ Hum Reprod; 2020 May; 35(5):1168-1177. PubMed ID: 32325487 [TBL] [Abstract][Full Text] [Related]
16. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891 [TBL] [Abstract][Full Text] [Related]
18. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576 [TBL] [Abstract][Full Text] [Related]
19. Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome-the FertIL trial. Wälchli-Popovic M; Monnerat S; Taylor AE; Gilligan LC; Schiffer L; Arlt W; Vogt DR; De Geyter C; Hutter N; Donath MY; Sartorius G; Christ-Crain M Front Endocrinol (Lausanne); 2024; 15():1435698. PubMed ID: 39324125 [TBL] [Abstract][Full Text] [Related]
20. Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. González F; Sia CL; Shepard MK; Rote NS; Minium J J Clin Endocrinol Metab; 2012 Nov; 97(11):4071-9. PubMed ID: 22904174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]